FBXO45 has been described as a tumor promoter or linked to the pathogenesis of pancreatic, esophageal, liver, gastric, lung, and breast carcinomas (23, 36, 37, 38, 39, 40, 41). Here, FBXO45 is linked to breast carcinoma.